Free Republic

Key Points The Food and Drug Administration said it is ending its emergency use authorization of chloroquine and hydroxychloroquine, the anti-malaria drugs backed by President Donald Trump to combat Covid-19. The agency determined the drugs were “unlikely to be effective in treating COVID-19 for the authorized uses in the EUA.” Trump disclosed last month he was taking hydroxychloroquine daily to prevent infection from the coronavirus. ========================================================================== The Food and Drug Administration said Monday it is ending its emergency use authorization of chloroquine and hydroxychloroquine, the anti-malaria drugs backed by President Donald Trump to combat Covid-19. The agency determined the drugs...

The Food and Drug Administration has withdrawn the emergency use authorization for two controversial coronavirus treatment drugs promoted by President Trump because of serious safety issues. The agency said recent clinical trial failures mean chloroquine and hydroxychloroquine may not be effective at treating COVID-19 or preventing it in people who have been exposed, and that their potential benefits do not outweigh the risks. Doctors have warned that the drugs can cause serious heart problems, but the FDA had previously allowed their use for hospitalized patients and during clinical trials. Trump spent weeks promoting the drugs as a potential miracle treatment...

MADISON (WKOW) -- Sen. Ron Johnson (R-WI) has organized a letter from physicians to push President Donald Trump to increase access to the Malaris drug Hydroxychloroquine. In his letter, he urges the President to remove restrictions that would allow patients to try the drug early in the course of their COVID-19 diagnosis. The first request is for the President to remove FDA Emergency Use Authorization restriction that states hydroxychloroquine (HCQ) and chloroquine (CQ) from the Strategic National Stockpile are only approved "for certain hospitalized patients. " Johnson also requests in the letter that President Trump issues an executive order to...

(CNN) — The US Food and Drug Administration (FDA) has issued an emergency use authorization for chloroquine and hydroxychloroquine to treat patients hospitalized with COVID-19. The drugs — which are used to treat malaria and other conditions — have been called game changers by President Donald Trump. But thus far, there is little scientific evidence that chloroquine, or its closely-related analogue hydroxychloroquine, are effective in treating Covid-19. What happened? The authorization came in a letter dated Saturday, but the US Department of Health and Human Services (HHS) acknowledged the FDA’s action in a Sunday news release. The FDA limited the...

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus. The Department of Health and Human Services (HHS) issued a statement on Sunday: The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible. HHS...

Teva Pharmaceutical Industries Ltd. (nyse and tase:TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to meet the urgent demand for the medicine as an investigational target to treat COVID-19. The company is also looking at additional ways to address the global need. “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” said Brendan O’Grady, Teva Executive Vice President, North America Commercial. “Immediately upon learning of the potential benefit of hyroxychloroquine, Teva began to...

The U.S. Food and Drug Administration (FDA) has approved the use of two anti-malaria drugs to treat patients infected by the new coronavirus. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. (EUA) That marked the first EUA for a drug related to COVID-19 in the U.S., according to the statement. Currently, there are no specific drugs for COVID-19 which, as shown...

Can an anti-malarial drug touted by the White House fight the acute version of the coronavirus infection? Yesterday, HHS Secretary Alex Azar announced that the FDA had granted physicians in the US an emergency authorization to prescribe chloroquine and hydroxychloroquine to certain patients with COVID-19 symptoms, based on initial successes with them in Europe. HHS will begin accepting tens of millions of doses for distribution to the “hot spots” around the nation: Scientists in America and around the world have identified multiple potential therapeutics for #COVID19, including chloroquine and hydroxychloroquine. President Trump is taking every possible step to protect...

I’ve been thinking of doing a “Transport Me There” meme for awhile. If ever there was a time to be transported this is it. So this is entry #1 in my “Transport Me There” vault.Yeah, yeah, yeah, I know, “social distancing” and all. But who couldn’t spend a day in this alley coffee shop with a laptop, Kindle or good book?**But for now we return to reality with a Wuhan Wave update: In the wake of an additional study of its efficacy Italy and France are now prescribing hydroxychloroquine and chloroquine as treatments for coronavirus patients. The U.S. has not...

What are the Democrat governors in Nevada and Michigan going to do now? – The Food and Drug Administration issued an emergency use autorization on Sunday, approving hydroxycholoroquine and chloroquine for use in treating the Wuhan Virus, COVID-19, after numerous successful studies and test cases emerged over the past three weeks. Democrat politicians and corrupt media outlets who are hoping this crisis lasts as long as possible in order to damage President Trump have been despicably down-playing the use of this safe, well-known, inexpensive and plentiful malaria treatment for the past two weeks. Two Democrat hack governors – Steve Sisolak...

The Food and Drug Administration on Sunday issued an emergency use authorization for hydroxychloroquine and chloroquine, decades-old malaria drugs championed by President Donald Trump for coronavirus treatment despite scant evidence. The agency allowed for the drugs to be "donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible," HHS said in a statement, announcing that Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine. (Please see link, for full...

ZURICH (Reuters) - Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday. Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which U.S. President Donald Trump also has been promoting, can be approved for use against the coronavirus. Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus. (Please see link, for full story)